MGX Stock: Metagenomi, Inc. Common Stock Stock Price, Analysis & Insights

Get live MGX stock price $1.25, comprehensive Metagenomi, Inc. Common Stock stock analysis, charts, news, and expert forecast. Real-time MGX stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

1.25

2.03%Today

MGX • Metagenomi, Inc. Common Stock • NASDAQ Global Select • Healthcare

Market Cap

47.25M

Volume

6.95K

52W High

3.95

52W Low

1.21

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development effort...

Contact Information

Website: https://www.metagenomi.co
Address: 5959 Horton Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: 0.65) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Metagenomi, Inc. Common Stock shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Metagenomi, Inc. Common Stock
⚠Investors should consider how Metagenomi, Inc. Common Stock fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

47.25M

P/E Ratio (TTM)

-0.55

Beta

0.65

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare MGX with peer companies:

Adverum Biotechnologies, Inc. (ADVM)

Price: $4.36
Market cap: 96.26M

ALX Oncology Holdings Inc. (ALXO)

Price: $1.58
Market cap: 212.58M

Artiva Biotherapeutics, Inc. (ARTV)

Price: $7.46
Market cap: 184.29M

aTyr Pharma, Inc. (ATYR)

Price: $0.47
Market cap: 46.17M

Connect Biopharma Holdings Limited (CNTB)

Price: $2.19
Market cap: 137.89M

Precision BioSciences, Inc. (DTIL)

Price: $7.03
Market cap: 90.12M

InflaRx N.V. (IFRX)

Price: $1.67
Market cap: 120.27M

Kalaris Therapeutics Inc (KLRS)

Price: $4.16
Market cap: 77.71M

Quince Therapeutics, Inc. (QNCX)

Price: $1.01
Market cap: 5.60M

Sutro Biopharma, Inc. (STRO)

Price: $26.97
Market cap: 261.00M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.